These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9921868)

  • 1. Normalization of creatine kinase level during arthritis in a patient with Becker muscular dystrophy.
    Maegaki Y; Ogura K; Maeoka Y; Takeshita K
    Neurology; 1999 Jan; 52(1):172-4. PubMed ID: 9921868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy.
    Ishitobi M; Haginoya K; Zhao Y; Ohnuma A; Minato J; Yanagisawa T; Tanabu M; Kikuchi M; Iinuma K
    Neuroreport; 2000 Dec; 11(18):4033-5. PubMed ID: 11192624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?
    Florence JM; Fox PT; Planer GJ; Brooke MH
    Neurology; 1985 May; 35(5):758-61. PubMed ID: 4039424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
    Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
    Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection-associated decrease of serum creatine kinase levels in Fukuyama congenital muscular dystrophy.
    Takeshita S; Saito Y; Oyama Y; Watanabe Y; Ikeda A; Iai M; Sato T; Ishigaki K; Ito SI
    Brain Dev; 2021 Mar; 43(3):440-447. PubMed ID: 33277141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Becker muscular dystrophy (BMD) and Klinefelter's syndrome: a possible cause of variable expression of BMD within a pedigree.
    Suthers GK; Manson JI; Stern LM; Haan EA; Mulley JC
    J Med Genet; 1989 Apr; 26(4):251-4. PubMed ID: 2716035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase?
    Kiessling WR; Beckmann R
    Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Duchenne and Becker muscular dystrophy in Chile].
    Holmgren J; Reyes J; Colombo M; Blanco MA
    Rev Med Chil; 1992 Mar; 120(3):288-92. PubMed ID: 1342481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy].
    Kondo F; Ikeda M; Abe E; Mue S
    Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary progressive muscular dystrophies: serum myoglobin pattern in patients with different types of muscular dystrophies.
    Pöche H; Kattner E; Beckmann R; Pernice W; Schneider V
    Clin Physiol Biochem; 1989; 7(1):40-6. PubMed ID: 2752671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies.
    Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M
    Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Soluble adhesion molecules in muscular dystrophy].
    Saito T; Yamamoto Y; Shinno S
    No To Hattatsu; 2002 Jul; 34(4):326-9. PubMed ID: 12134684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers.
    Straub RH; Georgi J; Helmke K; Vaith P; Lang B
    Rheumatology (Oxford); 2002 Apr; 41(4):423-9. PubMed ID: 11961173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.